Our study firstly demonstrated that ADCY9 gene polymorphisms were associated with HCC risk, especially rs2230742 significantly altered the susceptibility of HCC, and it confirmed that ADCY9 was involved in cancer development in previous studies (9). This evidence concerns the gene ADCY9 and hepatocellular carcinoma.